Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

In vivo regulation of hTERT expression and telomerase activity by androgen.

Guo C, Armbruster BN, Price DT, Counter CM.

J Urol. 2003 Aug;170(2 Pt 1):615-8.

PMID:
12853842
2.

Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.

Kyo S, Takakura M, Fujiwara T, Inoue M.

Cancer Sci. 2008 Aug;99(8):1528-38. doi: 10.1111/j.1349-7006.2008.00878.x. Review.

3.

Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.

Horikawa I, Barrett JC.

Carcinogenesis. 2003 Jul;24(7):1167-76. Epub 2003 May 22. Review.

4.

Regulation of the human telomerase reverse transcriptase gene.

Ducrest AL, Szutorisz H, Lingner J, Nabholz M.

Oncogene. 2002 Jan 21;21(4):541-52. Review.

5.

Androgen-regulated gene expression in prostate cancer.

Trapman J, Cleutjens KB.

Semin Cancer Biol. 1997 Feb;8(1):29-36. Review.

PMID:
9299579
6.

Telomerase as tumor marker.

Hiyama E, Hiyama K.

Cancer Lett. 2003 May 15;194(2):221-33. Review.

PMID:
12757980
7.

The importance of steroid hormones in prostate cancer.

Wilding G.

Cancer Surv. 1992;14:113-30. Review.

PMID:
1423327
8.

Androgens and the control of lipid metabolism in human prostate cancer cells.

Swinnen JV, Verhoeven G.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):191-8. Review.

PMID:
9699873
9.

The significance of human telomerase reverse transcriptase (hTERT) in cancer.

Kirkpatrick KL, Mokbel K.

Eur J Surg Oncol. 2001 Dec;27(8):754-60. Review.

PMID:
11735173
10.

Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).

Poole JC, Andrews LG, Tollefsbol TO.

Gene. 2001 May 16;269(1-2):1-12. Review.

PMID:
11376932
11.

[Molecular mechanisms involved in the regulation of telomerase activity].

Liu WJ, Ding J.

Sheng Li Ke Xue Jin Zhan. 2001 Jul;32(3):220-4. Review. Chinese.

PMID:
12545793
13.

[Telomerase].

Tsuji N, Watanabe N.

Rinsho Byori. 2002 Nov;Suppl 123:137-41. Review. Japanese.

PMID:
12652801
14.

[Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives].

Verhoeven G.

Verh K Acad Geneeskd Belg. 2002;64(3):189-95; discussion 195-6. Review. Dutch.

PMID:
12238242
15.

[Mechanism on androgen-independent progression of prostate cancer].

Shimazaki J, Akakura K, Furuya Y, Ito H.

Nihon Rinsho. 1997 May;55(5):1143-8. Review. Japanese.

PMID:
9155166
16.

Molecular action of androgen in the normal and neoplastic prostate.

Kokontis JM, Liao S.

Vitam Horm. 1999;55:219-307. Review. No abstract available.

PMID:
9949683
17.

Telomerase activity modulation in the prevention of prostate cancer.

Kim NW, Hruszkewycz AM.

Urology. 2001 Apr;57(4 Suppl 1):148-53. Review.

PMID:
11295615
18.

Telomerase as a therapeutic target for malignant gliomas.

Komata T, Kanzawa T, Kondo Y, Kondo S.

Oncogene. 2002 Jan 21;21(4):656-63. Review.

19.

The role of steroid hormones in prostate carcinogenesis.

Bosland MC.

J Natl Cancer Inst Monogr. 2000;(27):39-66. Review.

PMID:
10963619
20.

Tumor cell redox state and mitochondria at the center of the non-canonical activity of telomerase reverse transcriptase.

Indran IR, Hande MP, Pervaiz S.

Mol Aspects Med. 2010 Feb;31(1):21-8. doi: 10.1016/j.mam.2009.12.001. Epub 2009 Dec 6. Review.

PMID:
19995569
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk